Edesa Biotech News

Edesa Biotech Showcases Innovation at Investor Conference

TipRanksApr 11 16:37 ET

Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference

TORONTO, ON / ACCESSWIRE / April 11, 2024 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory disea

AccesswireApr 11 09:00 ET

Edesa Biotech to Participate in Upcoming Investor Conferences

TORONTO, ON / ACCESSWIRE / April 2, 2024 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseas

AccesswireApr 2 09:00 ET

Edesa Biotech(EDSA.US) 10% Shareholder Buys US$20,000 in Common Stocks

$Edesa Biotech(EDSA.US)$ 10% Shareholder Nijhawan Pardeep purchased 5,000 shares of Common Stocks on Mar 25, 2024 at an average price of $4 for a total value of $20,000. This transaction involves othe

moomoo NewsMar 25 19:43 ET

Edesa Biotech Shines at Autoimmune Conference

TipRanksMar 22 00:37 ET

Edesa Biotech to Participate in HC Wainwright Autoimmune & Inflammatory Conference

TORONTO, ON / ACCESSWIRE / March 21, 2024 / Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory disea

AccesswireMar 21 16:30 ET

Edesa Biotech Showcases Innovations at Healthcare Conference

TipRanksMar 7 16:07 ET

Edesa Biotech to Participate in Barclays Global Healthcare Conference

TORONTO, ON / ACCESSWIRE / March 7, 2024 / Edesa Biotech, Inc. , a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, announced today

AccesswireMar 7 08:45 ET

Edesa Biotech Showcases Innovations at Dermatology Events

TipRanksMar 4 23:07 ET

Edesa Biotech to Participate in Upcoming Dermatology Meetings

TORONTO, ON / ACCESSWIRE / March 4, 2024 / Edesa Biotech, Inc. , a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, announced today

AccesswireMar 4 16:30 ET

Analysts Offer Insights on Healthcare Companies: Incyte (INCY), Edesa Biotech (EDSA) and Ocular Therapeutix (OCUL)

TipRanksFeb 14 06:30 ET

Express News | HC Wainwright & Co. Reiterates Buy on Edesa Biotech, Maintains $21 Price Target

Moomoo 24/7Feb 14 06:27 ET

Edesa Biotech GAAP EPS of -$0.54 Beats by $0.67

Seeking AlphaFeb 9 16:23 ET

Edesa Biotech Reports Fiscal 1st Quarter 2024 Results

TORONTO, ON / ACCESSWIRE / February 9, 2024 / Edesa Biotech, Inc. , a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today

AccesswireFeb 9 16:15 ET

Edesa Biotech to Participate in Dermatology Summit and JP Morgan Week

TORONTO, ON / ACCESSWIRE / January 4, 2024 / Edesa Biotech, Inc. , a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, announced

AccesswireJan 4 16:15 ET

Edesa Biotech FY23 EPS $(2.93) Down From $(8.37) YoY

Edesa Biotech FY23 EPS $(2.93) Down From $(8.37) YoY

BenzingaDec 15, 2023 16:13 ET

Edesa Biotech Reports Fiscal Year 2023 Results

TORONTO, ON / ACCESSWIRE / December 15, 2023 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory di

AccesswireDec 15, 2023 16:10 ET

Top Premarket Decliners

Global Water Resources (GWRS) shares tumbled 20% Wednesday premarket following a 1.4% gain in the previous session. Loop Media (LPTV) shares fell nearly 19% after the company reported lower fiscal Q4

MT NewswiresDec 13, 2023 07:51 ET

PAVM, CCLD and EDSA Among Mid-day Movers

Seeking AlphaDec 12, 2023 12:30 ET

Edesa Biotech Is Maintained at Buy by HC Wainwright & Co.

Edesa Biotech Is Maintained at Buy by HC Wainwright & Co.

Dow JonesNov 29, 2023 06:45 ET